Antibiotic Resistance In A Single Health Approach

Öz

Antimicrobial resistance has become an increasingly important health problem in both human and veterinary medicine all over the world. The main reason for the resistance to antibiotics, which are critical agents in the treatment and control of life-threatening bacterial infections, is the overuse and misuse of these weapons. Considering this reason and considering the widespread presence of resistant microorganisms in the environment, it is seen that a holistic and unifying approach, expressed as One Health, is needed to solve the aforementioned problem. On the basis of this approach, which aims to balance and optimize the health of humans, animals and ecosystems in a sustainable way, it is seen that the continuation and spread of resistance development can be minimized with the organizations to be established at regional, national and international levels and the policies to be carried out.

Anahtar Kelimeler

• Antibiotic resistance
• multidrug resistance
• One Health

TEK SAĞLIK YAKLAŞIMINDA ANTİBİYOTİK DİRENÇLİLİĞİ

Öz

Antimikrobiyel direnç, tüm dünyada gerek insan gerekse veteriner hekimliğinde giderek büyüyen önemli bir sağlık problemi haline gelmiştir. Özellikle yaşamı tehdit eden bakteriyel enfeksiyonların tedavisinde ve kontrol altına alınmasında kritik öneme sahip ajanlar olan antibiyotiklere karşı gelişen direncin en büyük sebebi bu silahların aşırı ve yanlış kullanılmalarıdır. Bu sebep göz önüne alındığında ve dirençli mikroorganizmaların çevrede yaygın bir şekilde bulunabildiği düşünüldüğünde, söz konusu problemin çözümü için Tek Sağlık olarak ifade edilen bütüncül ve birleştirici bir yaklaşıma ihtiyaç duyulduğu görülmektedir. İnsanların, hayvanların ve ekosistemlerin sağlığını sürdürülebilir bir şekilde dengelemeyi ve optimize etmeyi amaçlayan bu yaklaşım temelinde bölgesel, ulusal ve uluslararası düzeylerde oluşturulacak organizasyonlar ve yürütülecek politikalarla direnç gelişiminin devam etmesi ve yayılması en aza indirilebilir görülmektedir.

Anahtar Kelimeler

• antibiyotik;
• direnç
• tek sağlık
• Antibiotic resistance
• multidrug resistance
• One Health

Kaynakça

1. KAYNAKLAR Bengtsson, B. & Greko, C. (2014). “Antibiotic resistance--consequences for animal health, welfare, and food production” . Upsala Journal of Medical Sciences, 119 (2): 96-102.
2. European Centre for Disease Prevention and Control (2019). Antimicrobial Consumption in the EU/EEA, Annual Epidemiological Report for 2018.
3. ECDC (2020). The European Surveillance System Antimicrobial Consumption (AMC) Reporting Protocol 2020.
4. Jonathan, R., Ferreira, J.P. & Stark, K.D.C. (2014). “Antimicrobial resistance: the use of antimicrobials in the livestock sector”. Paris.
5. NIH (2020). Causes of antimicrobial (drug) resistance.
6. https://www.niaid.nih.gov/research/antimicrobialresistance-causes
7. Pokharel, S., Shrestha, P. & Adhikari, B. (2020). “Antimicrobial use in food animals and human health: time to implement ‘One Health’ approach”. Antimicrobial Resistance & Infection Control, 9, 181.
8. Lipsitch, M. & Samore, M.H. (2022). “Antimicrobial use and antimicrobial resistance: a population perspective”. Emerging Infectious Diseases, 8 (4): 347-354.

9. Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A.K.M., Wertheim, H.F.L., Sumpradit, N., Vlieghe, E., Hara, G.L., Durand, C.G. & Aires, B. (2014). “Antibiotic resistance—the need for global solutions”. The Lancet Infectious Diseases, 13: 1057-1098.
10. Llor, C. & Bjerrum, L. (2014). “Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem”. Therapeutic Advances in Drug Safety, (6): 229-241.
11. Martinez, J.L. & Baquero, F. (2002). “Interactions among strategies associated with bacterial infections: pathogenicity, epidemicity, and antibiotic resistance”. Clinical Microbiology Reviews, 15: 647-679.
12. Mulani, M.S., Kamble, E.E., Kumkar, S.N., Tawre, M.S. & Pardesi, K.R. (2019). «Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review». Frontiers in Microbiology. 10: 539.
13. National Research Council, Committee on Drug Use in Food Animals (1999). “The use of drugs in food animals: benefits and risks”. Washington (DC): National Academy Press.
14. O’neill, J. (2016). “Tackling Drug Resistant Infections Globally: Final Report and Recommendation”. The Review on Antimicrobial Resistance. 64
15. Queenan, K., Häsler, B. & Rushton, J. (2016) “A One Health approach to antimicrobial resistance surveillance: is there a business case for it?”. International Journal of Antimicrobial Agents, 48, 422-427.
16. Sun, D., Jeannot, K., Xiao, Y. & Knapp, C.W. (2019). “Editorial: Horizontal Gene Transfer Mediated Bacterial Antibiotic Resistance”. Frontiers in Microbiology. 10: 1933.
17. Gıda ve Kontrol Genel Müdürlüğü (2018-2023). “ Antimikrobiyal Direnç Önleme Stratejik Eylem Planı Önceliklendirilme ve Maliyetlendirme Aracı Geliştirilmesi Çalıştayı”. https://www.tarimorman.gov.tr/GKGM/ Haber/274/Antimikrobiyal-Direnc-Onleme-Stratejik-Eylem-Plani-Onceliklendirilme-Ve-Maliyetlendirme-Ar aci-Gelistirilmesi-Calistayi.
18. Yıldız, S.S., Şimşek, H., Çöplü, N., Gülay, Z. & UAMDSS Çalışma Grubu. (2017). “Ulusal Antimikrobiyal Direnç Sürveyans Sistemi (UAMDSS) Dış Kalite Değerlendirme Çalışmaları: 2011-2016 National Antimicrobial Resistance Surveillance System (NAMRSS) External Quality Assessment Studies: 2011-2016”.
19. Mikrobiyoloji Bülteni, 51(3): 247-259.
20. Wegener, H.C. (2012). Antibiotic Resistance-Linking Human And Animal Health. In: Institute of Medicine (US). Improving Food Safety Through a One Health Approach: Workshop Summary. Washington (DC): National Academies Press (US).
21. WHO. (2021). “Antimicrobial resistance”. https://www.who.int/news-room/fact-sheets/detail/antimicrobialresistance
22. WHO. (2019). “No time to wait: securing the future from drug-resistant”. infections. https://www.who.int/ docs/default-source/documents/no-time-to-wait-securing-the-future-from-drug-resistant-infections-en. pdf?sfvrsn=5b424d7_6.
23. WHO. (2017). “Global priority list of antibiotic-resistant bacteria to guide research, discover, and development of new antibiotics”. http://remed.org/wp-content/uploads/2017/03/lobal-priority-list-of-antibioticresistant-bacteria-2017.pdf.